175 related articles for article (PubMed ID: 30988076)
1. Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α.
Liu D; Li H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988076
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells.
Luo F; Liu X; Ling M; Lu L; Shi L; Lu X; Li J; Zhang A; Liu Q
Biochim Biophys Acta; 2016 Sep; 1862(9):1685-95. PubMed ID: 27287256
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of LncRNA GHET1 suppresses prostate cancer cell proliferation by inhibiting HIF-1α/Notch-1 signaling pathway via KLF2.
Zhu Y; Tong Y; Wu J; Liu Y; Zhao M
Biofactors; 2019 May; 45(3):364-373. PubMed ID: 30609158
[TBL] [Abstract][Full Text] [Related]
4. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
Liu T; Zhao L; Chen W; Li Z; Hou H; Ding L; Li X
Int J Mol Med; 2014 May; 33(5):1236-42. PubMed ID: 24549370
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
[TBL] [Abstract][Full Text] [Related]
8. LINK-A Long Non-Coding RNA (lncRNA) Participates in Metastasis of Ovarian Carcinoma and Upregulates Hypoxia-Inducible Factor 1 (HIF1α).
Zhang H; Yao B; Tang S; Chen Y
Med Sci Monit; 2019 Mar; 25():2221-2227. PubMed ID: 30912527
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
Liu N; Xia WY; Liu SS; Chen HY; Sun L; Liu MY; Li LF; Lu HM; Fu YJ; Wang P; Wu H; Gao JX
Sci Rep; 2016 Feb; 6():20489. PubMed ID: 26841847
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
12. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)-mediated induction of the long noncoding RNA NICI.
Lauer V; Grampp S; Platt J; Lafleur V; Lombardi O; Choudhry H; Kranz F; Hartmann A; Wullich B; Yamamoto A; Coleman ML; Ratcliffe PJ; Mole DR; Schödel J
J Biol Chem; 2020 Mar; 295(13):4065-4078. PubMed ID: 31690629
[TBL] [Abstract][Full Text] [Related]
14. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions.
Jung YS; Lee SJ; Yoon MH; Ha NC; Park BJ
Cell Cycle; 2012 Dec; 11(23):4462-73. PubMed ID: 23159849
[TBL] [Abstract][Full Text] [Related]
16. MIR-92 stimulates VEGF by inhibiting von Hippel-Lindau gene product in epithelial ovarian cancer.
Guo FJ; Shao YP; Wang YP; Jin YM; Liu SS; Wang QY
J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):615-624. PubMed ID: 28952293
[TBL] [Abstract][Full Text] [Related]
17. TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL.
Chen K; Chen S; Huang C; Cheng H; Zhou R
Biol Cell; 2013 May; 105(5):208-218. PubMed ID: 23387829
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glucose metabolism by p62/SQSTM1 through HIF1α.
Chen K; Zeng J; Xiao H; Huang C; Hu J; Yao W; Yu G; Xiao W; Xu H; Ye Z
J Cell Sci; 2016 Feb; 129(4):817-30. PubMed ID: 26743088
[TBL] [Abstract][Full Text] [Related]
19. A novel hypoxia-stimulated lncRNA HIF1A-AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription.
Xie W; Wang W; Meng S; Wu X; Liu X; Liu Y; Kang X; Su Y; Lv X; Guo L; Wang C
Mol Carcinog; 2023 Dec; 62(12):1860-1876. PubMed ID: 37589417
[TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
